sglt2 inhibitors and glp 1 agonist GLP-1 Receptor Agonists in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs SGLT2 Inhibitors and GLP-1 Receptor

The GLP-1 market represents a major therapeutic class by revenue in the United States pharmaceutical landscape, with continued expansion expected

Tranexamic Acid: An active ingredient known for its ability to inhibit melanin synthesis, thus reducing dark spots and uneven skin tone

Coagulation factor Xa and protease-activated receptor 2 as novel therapeutic targets for diabetic nephropathy

doi:10.1590/S1516-89132013000500017 Ask M, Mapelli V, Hck H, Olsson L, Bettiga M (2013) Engineering glutathione biosynthesis of Saccharomyces cerevisiae increases robustness to inhibitors in pretreated lignocellulosic materials

For more information, ask to speak to the Pharmacist

Interaction between the tumor microenvironment and resection margin in different gross types of hepatocellular carcinoma